EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Cost-effectiveness of Preventive Transarterial Embolization for Splenic Artery Aneurysm Below the Guideline-Recommended Size Threshold: A Japanese Claims-Based Study

Go Shirota, So Sato, Hideo Yasunaga, Yuichiro Matsuo, Masaaki Akahane, Daisuke Itoh, Osamu Abe

Journal of Vascular and Interventional Radiology · 2026

DOI: 10.1016/j.jvir.2025.09.021 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Vascular and Interventional Radiology, 2026. Verfasst von Go Shirota und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: gshirota@gmail.com. Hauptthemen laut MEDLINE: Splenic Artery, Embolization, Therapeutic, Aneurysm, Health Care Costs. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, University of Tokyo, Government of Japan Ministry of Health Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Preventive transarterial embolization (TAE) for splenic artery aneurysm (SAA) is recommended in high-risk cases owing to the high mortality after rupture. This study evaluated the cost effectiveness of preventive TAE for SAAs smaller than guideline-recommended threshold of 30 mm. MATERIALS AND METHODS: A Markov model with 6 states (well without treatment, well after treatment, TAE for aneurysm growth, recanalization, rupture, and death) was developed to compare preventive TAE with the watch-and-wait strategy using 1-year cycles over a lifetime. Model parameters were derived from prior studies and a national administrative claims database in Japan. The base case was a 60-year-old female with SAA measuring 20 mm. The incremental cost-effectiveness ratio (ICER) was evaluated against Japan's willingness-to-pay threshold of 5 million yen per quality-adjusted life year (QALY). Deterministic and probabilistic sensitivity analyses incorporated scenarios varying multiple parameters. RESULTS: Analysis of 2,870 patients undergoing preventive TAE for SAAs from the database revealed an ICER of 3,522,204 yen/QALY (22,724 USD/QALY) in the base case, below the threshold. The ICER exceeded the threshold at 71.4 years in females and 65.9 in males. Quality-of-life (QOL) improvement by treatment (12-24 months and longer), time to QOL difference resolution, age at discovery, and costs of preventive TAE were the key ICER influencers. Without QOL improvement, preventive TAE was not cost-effective. CONCLUSIONS: Preventive TAE for SAA may be cost-effective but only when treatment leads to improvements in QOL. These findings highlight the importance of patient selection and can guide cost-conscious clinical decision-making and reimbursement policy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Splenic ArteryEmbolization, TherapeuticAneurysmHealth Care CostsHumansCost-Benefit AnalysisJapanFemaleMiddle AgedMarkov ChainsQuality-Adjusted Life YearsModels, EconomicTreatment OutcomeMaleTime FactorsAgedAdministrative Claims, HealthcareDatabases, FactualPractice Guidelines as TopicWatchful WaitingEast Asian People

Autor:innen und Institutionen

  • Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: gshirota@gmail.com.
  • Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
  • Department of Radiology, International University of Health and Welfare Narita Hospital, Narita, Japan.
  • Department of Diagnostic Radiology, Toranomon Hospital, Tokyo, Japan.
  • Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • University of Tokyo
  • Government of Japan Ministry of Health Labour and Welfare

Zitieren

APA

Shirota, G., Sato, S., Yasunaga, H., Matsuo, Y., Akahane, M., Itoh, D., & Abe, O. (2026). Cost-effectiveness of Preventive Transarterial Embolization for Splenic Artery Aneurysm Below the Guideline-Recommended Size Threshold: A Japanese Claims-Based Study. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2025.09.021

Vancouver

Shirota G, Sato S, Yasunaga H, Matsuo Y, Akahane M, Itoh D, et al. Cost-effectiveness of Preventive Transarterial Embolization for Splenic Artery Aneurysm Below the Guideline-Recommended Size Threshold: A Japanese Claims-Based Study. Journal of Vascular and Interventional Radiology. 2026. doi:10.1016/j.jvir.2025.09.021

BibTeX
@article{Shirota2026,
  author = {Shirota, Go and Sato, So and Yasunaga, Hideo and Matsuo, Yuichiro and Akahane, Masaaki and Itoh, Daisuke and Abe, Osamu},
  title = {Cost-effectiveness of Preventive Transarterial Embolization for Splenic Artery Aneurysm Below the Guideline-Recommended Size Threshold: A Japanese Claims-Based Study},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2026},
  doi = {10.1016/j.jvir.2025.09.021}
}
Kostenlos starten →